FDA Issues Recall for Apothecary Pharma's Injectable GLP-1 Medications Due to Sterility Concerns
A significant recall has been initiated by Apothecary Pharma, affecting 23 vials of injectable drugs distributed nationwide due to concerns over sterility. The Food and Drug…
DO
By Daniel Okafor · Regulatory Correspondent
Oct 21 02:42 ETSource: SSBCrack
From the source
Read at news.ssbcrack.comFDA Issues Recall for Apothecary Pharma's Injectable GLP-1 Medications Due to Sterility Concerns
A significant recall has been initiated by Apothecary Pharma, affecting 23 vials of injectable drugs distributed nationwide due to concerns over sterility. The Food and Drug Administration (FDA) classified this recall as Class II on October 8, suggesting that while serious health consequences are considered unlikely, there are still potential risks for patients.
